CN Patent

CN101014332A — 角膜结膜病变治疗剂

Assigned to Santen Pharmaceutical Co Ltd · Expires 2007-08-08 · 19y expired

What this patent protects

本发明的目的在于探索E－4－[4－(5－甲基－2－苯基－4－噁唑基甲氧基)苄氧基亚氨基]－4－苯基丁酸、Z－2－[4－(5－甲基－2－苯基－4－噁唑基甲氧基)苄氧基亚氨基]－2－(4－苯氧基苯基)乙酸、2－[2－丙基－3－[3－[2－乙基－4－(4－氟苯基)－5－羟基苯氧基]丙氧基]苯氧基]苯甲酸、2(S)－甲氧基－3－[4－[3－(4－苯氧基苯氧基)丙氧基]苯基]丙酸或上述化合物的盐的新型医药用途。上述羧酸化合物或其盐均对角膜病变模型发挥优良的改善效果，可有效用作干眼症、角膜溃疡、角膜炎、结膜炎、浅层点状角膜病变、角膜上皮缺损、结膜上皮缺损、干性角膜结…

USPTO Abstract

本发明的目的在于探索E－4－[4－(5－甲基－2－苯基－4－噁唑基甲氧基)苄氧基亚氨基]－4－苯基丁酸、Z－2－[4－(5－甲基－2－苯基－4－噁唑基甲氧基)苄氧基亚氨基]－2－(4－苯氧基苯基)乙酸、2－[2－丙基－3－[3－[2－乙基－4－(4－氟苯基)－5－羟基苯氧基]丙氧基]苯氧基]苯甲酸、2(S)－甲氧基－3－[4－[3－(4－苯氧基苯氧基)丙氧基]苯基]丙酸或上述化合物的盐的新型医药用途。上述羧酸化合物或其盐均对角膜病变模型发挥优良的改善效果，可有效用作干眼症、角膜溃疡、角膜炎、结膜炎、浅层点状角膜病变、角膜上皮缺损、结膜上皮缺损、干性角膜结膜炎、上轮部角膜结膜炎或丝状角膜炎等角膜结膜病变的治疗剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN101014332A
Jurisdiction
CN
Classification
—
Expires
2007-08-08
Drug substance claim
No
Drug product claim
No
Assignee
Santen Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.